The use of an insuflon device for the administration of G-CSF in pediatric cancer patients

Support Care Cancer. 2006 Jan;14(1):98-100. doi: 10.1007/s00520-005-0872-x. Epub 2005 Aug 12.

Abstract

In pediatric oncology, granulocyte colony-stimulating factor (G-CSF) is applied with the aim of shortening neutropenic periods after chemotherapy and for mobilization of peripheral blood stem cells for apheresis procedures. G-CSF is administered, subcutaneously or intravenously, on a daily basis. An insuflon device for the administration of G-CSF was used in 29 patients for 93 G-CSF periods. Retrospective evaluation shows that this administration route is feasible, safe and preferred by young children rather than by teenagers with cancer.

MeSH terms

  • Adolescent
  • Anemia, Aplastic / chemically induced
  • Anemia, Aplastic / prevention & control*
  • Antineoplastic Agents / adverse effects*
  • Child
  • Child, Preschool
  • Equipment Design
  • Equipment Safety
  • Feasibility Studies
  • Granulocyte Colony-Stimulating Factor / administration & dosage*
  • Granulocyte Colony-Stimulating Factor / adverse effects
  • Humans
  • Injections, Intravenous / instrumentation
  • Injections, Subcutaneous / instrumentation
  • Neoplasms / drug therapy*
  • Quality of Life
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Granulocyte Colony-Stimulating Factor